✦ LIBER ✦

Safety and Clinical Outcome for Phase 2 Study of Nimotuzumab and Concurrent Capecitabine and Radiation Therapy for Patients With Locally-Advanced Inoperable or Relapsed/Residual Gastric Cancer

✍ Scribed by Lu, N.; Jin, J.; Li, Y.; Ren, H.; Fang, H.; Liu, Y.; Wang, W.; Wang, S.; Song, Y.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective Phase 2 Trial of Nimotuzumab

✍ Lu, N.; Jin, J.; Li, Y.; Ren, H.; Fang, H.; Liu, Y.; Wang, W.; Wang, S.; Song, Y 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

A Phase I Study of Concurrent Capecitabi

✍ Wang, X.; Jing, J.; Li, Y.; Wang, S.; Wang, W.; Song, Y.; Liu, Y.; Ren, H.; Fang 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Radiation Therapy Oncology Group 0247: A

✍ Stuart J. Wong; Kathryn Winter; Neal J. Meropol; Pramila Rani Anne; Lisa Kachnic 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Comparison of 2 Preoperative Chemoradiat

✍ Lee, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A Randomized Phase III Trial of Combined

✍ Dennis L. Carter; David Garfield; James Hathorn; Richard Mundis; Kristi A. Boehm 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 375 KB

Toxicity and Response of Pemetrexed Plus

✍ J.H. Heinzerling; R.S. Hughes; R. Govindan; J.D. Bradley; J.D. Schiller; G. Peng 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB